Novel oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) and diabetes—Good or excellent?
Sign Up to like & getrecommendations! Published in 2017 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.2893
Abstract: Atrial fibrillation (AF) is associated with an increased risk of stroke, systemic embolism, and death. In the last decade, novel oral anticoagulants (NOACs) have emerged and are nowadays a key player in the anticoagulant armamentarium… read more here.
Keywords: atrial fibrillation; oral anticoagulants; anticoagulants noacs; novel oral ... See more keywords
The Role of New Oral Anticoagulants (NOACs) in Cancer Patients.
Sign Up to like & getrecommendations! Published in 2017 at "Advances in experimental medicine and biology"
DOI: 10.1007/5584_2016_112
Abstract: New oral anticoagulants (NOACs) are likely to have a major impact in the next few years, changing clinical practice of anticoagulation therapy. Evidence on its efficacy and superiority to vitamin K antagonists (VKAs) in treating… read more here.
Keywords: oral anticoagulants; anticoagulants noacs; role new; cancer ... See more keywords